Curcumin Suppresses Colorectal Cancer Growth and Metastasis by Inhibiting NF-κB Activity

Chapter

Abstract

The third most malignant disease diagnosed worldwide is colorectal cancer (CRC). CRC treatment by chemo- and radiotherapy is challenging due to the cancer’s ability to activate major transcription factors such as NF-κB. Curcumin, a phytochemical, is known to downregulate NF-κB signaling in CRC cell lines and to exhibit anticarcinogenic properties. Therefore, curcumin and its analogues are novel therapeutic agents that could be used in the treatment of CRC growth and metastasis.

Keywords

Colorectal cancer Curcumin NF-κB Growth 

References

  1. 1.
    Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29CrossRefPubMedGoogle Scholar
  2. 2.
    Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer a pooled analysis. J Clin Oncol 22:1785–1796CrossRefPubMedGoogle Scholar
  3. 3.
    Koopman M, Venderbosch S, Van Tinteren H, Ligtenberg MJ, Nagtegaal I, Van Krieken JH, Punt CJ (2009) Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study. Eur J Cancer 45:1999–2006CrossRefPubMedGoogle Scholar
  4. 4.
    Samuel T, Fadlalla K, Gales DN, Putcha BD, Manne U (2014) Variable NF-kappaB pathway responses in colon cancer cells treated with chemotherapeutic drugs. BMC Cancer 14:599CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Fan Y, Mao R, Yang J (2013) NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 4:176–185CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wang S, Liu Z, Wang L, Zhang X (2009) NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 6:327–334CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ (2009) HIF-1α and HIF-2α have divergent roles in colon cancer. Int J Cancer 124:763–771CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Suzuki H, Gabrielson E, Chen W, Anbazhagan R, Van M, Engeland M, Weijenberg P, Herman JG, Baylin SB (2002) A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141–149CrossRefPubMedGoogle Scholar
  9. 9.
    Russo M, Spagnuolo C, Tedesco I, Russo GL (2010) Phytochemicals in cancer prevention and therapy: truth or dare? Toxins 2:517–551CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85–94CrossRefPubMedGoogle Scholar
  11. 11.
    Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41:40–59CrossRefPubMedGoogle Scholar
  12. 12.
    Epelbaum R, Schaffer M, Vizel B, Badmaev V, Bar-Sela G (2010) Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 62:1137–1141CrossRefPubMedGoogle Scholar
  13. 13.
    Thangapazham RL, Sharma A, Maheshwari RK (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8:E443–E449CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Nagaraju GP, Aliya S, Zafar SF, Basha R, Diaz R, El-Rayes BF (2012) The impact of curcumin on breast cancer. Integr Biol 4:996–1007CrossRefGoogle Scholar
  15. 15.
    Park W, Amin AR, Chen ZG, Shin DM (2013) New perspectives of curcumin in cancer prevention. Cancer Prev Res 6:387–400CrossRefGoogle Scholar
  16. 16.
    Nirmala MJ, Samundeeswari A, Sankar PD (2011) Natural plant resources in anti-cancer therapy-a review. Res Plant Biol 1:01–14Google Scholar
  17. 17.
    Mimeault M, Batra SK (2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chin Med 6:8546–8546CrossRefGoogle Scholar
  18. 18.
    Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd 2017

Authors and Affiliations

  1. 1.Department of Hematology and Medical Oncology, Winship Cancer InstituteEmory UniversityAtlantaUSA
  2. 2.Department of Zoology and Department of BiotechnologyBerhampur UniversityBerhampurIndia

Personalised recommendations